{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:12:25Z","timestamp":1788019945959,"version":"build-2784847793"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>To compare CTV<jats:sub>HR<\/jats:sub> and OAR dimensions and inter-rater agreement between magnetic resonance (MR) and trans-rectal ultrasound (TRUS) images in IB cervical cancer patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>IB cervical cancer patients treated with (chemo)radiotherapy plus MR-guided brachytherapy (BT) were prospectively enrolled in this study. Radiation oncologists contoured CTV<jats:sub>HR<\/jats:sub> and OARs in pre-BT MR images (MRI) and intra-operative TRUS images. These contours were subsequently compared in regard to volume and dimension. Contour inter-rater agreement analysis was also investigated using kappa index (KI). Stata 15.0 was used for statistical analysis and a <jats:italic>p<\/jats:italic>-value &lt;\u20090.05 was considered statistically significant.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>TRUS CTV<jats:sub>HR<\/jats:sub> volumes were statistically smaller than the respective MRI contoured volumes. TRUS CTV<jats:sub>HR<\/jats:sub> thickness was found to be consistently smaller than MRI contours in all patients. No statistical difference was seen in width and height between the two different imaging modalities. MRI contours had a median KI of 0.66 (range: 0.56\u20130.77) while TRUS-based contours had a median KI of 0.64 (range: 0.47\u20130.77). Bladder and rectum had very satisfactory KI in both imaging modalities. Vaginal contours had moderate agreement in MR (0.52) and in TRUS images (0.58).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>TRUS images allow good visualization of CTV<jats:sub>HR<\/jats:sub> and OARs in IB cervical cancer patients. Inter-rater contour variability was comparable between TRUS and MR images. TRUS is a promising modality on its own for image-guided BT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13014-020-01516-4","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:04:06Z","timestamp":1586196246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of CTVHR and organs at risk contours between TRUS and MR images in IB cervical cancers: a proof of concept study"],"prefix":"10.1186","volume":"15","author":[{"given":"Lucas C.","family":"Mendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Martell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Raziee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Alayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Wronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Taggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"1516_CR1","unstructured":"World Health Organization. Available from: https:\/\/www.who.int\/cancer\/prevention\/diagnosis-screening\/cervical-cancer\/en\/. [cited 2019 Mar 10]."},{"key":"1516_CR2","doi-asserted-by":"publisher","unstructured":"Mendez LC, Moraes FY, Fernandes G dos S, Weltman E. Cancer Deaths due to Lack of Universal Access to Radiotherapy in the Brazilian Public Health System. Clin Oncol (R Coll Radiol). 2018;30(1):e29\u201336. https:\/\/doi.org\/10.1016\/j.clon.2017.09.003.","DOI":"10.1016\/j.clon.2017.09.003"},{"key":"1516_CR3","doi-asserted-by":"publisher","unstructured":"Mendez LC, Moraes FY, Castilho MS, Louie AV, Qu XM. Lives and Economic Loss in Brazil due to Lack of Radiotherapy Access in Cervical Cancer: A Cost-Effectiveness Analysis. Clin Oncol (R Coll Radiol). 2019;31(9):e143\u20138. https:\/\/doi.org\/10.1016\/j.clon.2019.05.004.","DOI":"10.1016\/j.clon.2019.05.004"},{"key":"1516_CR4","doi-asserted-by":"publisher","unstructured":"Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical Cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.05.033.","DOI":"10.1016\/j.ijrobp.2013.05.033"},{"issue":"2","key":"1516_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","volume":"135","author":"EC Rijkmans","year":"2014","unstructured":"Rijkmans EC, Nout RA, Rutten IHHM, Ketelaars M, Neelis KJ, Laman MS, et al. Gynecologic oncology improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol. 2014;135(2):231\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2014.08.027.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.prro.2015.11.003","volume":"6","author":"K Chan","year":"2016","unstructured":"Chan K, Rosewall T, Kenefick B, Milosevic M. MR-guided brachytherapy for cervical cancer: quantifying process waste and identifying opportunities for system performance improvement. Pract Radiat Oncol. 2016;6(4):233\u201340. https:\/\/doi.org\/10.1016\/j.prro.2015.11.003.","journal-title":"Pract Radiat Oncol"},{"key":"1516_CR7","doi-asserted-by":"crossref","unstructured":"Smith WL, Lewis C, Bauman G, Rodrigues G, D'Souza D, Ash R, et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys. 2007;67(4):1238\u201347.","DOI":"10.1016\/j.ijrobp.2006.11.027"},{"issue":"3","key":"1516_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","volume":"74","author":"C Haie-Meder","year":"2005","unstructured":"Haie-Meder C, P\u00f6tter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235\u201345.","journal-title":"Radiother Oncol"},{"key":"1516_CR9","unstructured":"Viera AJ, Garrett JM. Understanding Interobserver Agreement: The Kappa Statistic; Fam Med. 2005;37(5):360\u20133."},{"key":"1516_CR10","doi-asserted-by":"publisher","unstructured":"P\u00f6tter R, Georg P, Dimopoulos JCA, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116\u201323. https:\/\/doi.org\/10.1016\/j.radonc.2011.07.012.","DOI":"10.1016\/j.radonc.2011.07.012"},{"key":"1516_CR11","doi-asserted-by":"crossref","unstructured":"Ogbole GI, Adeyomoye AO, Badu-Peprah A, Mensah Y, Nzeh DA. Survey of magnetic resonance imaging availability in West Africa. Pan Afr Med J. 2018;30:240.","DOI":"10.11604\/pamj.2018.30.240.14000"},{"key":"1516_CR12","doi-asserted-by":"publisher","unstructured":"Schmid MP, Nesvacil N, P\u00f6tter R, Kronreif G, Kirisits C. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer \u2013 An alternative to MRI for target definition. Radiother Oncol. 2016;120(3):467\u201372. https:\/\/doi.org\/10.1016\/j.radonc.2016.01.021.","DOI":"10.1016\/j.radonc.2016.01.021"},{"key":"1516_CR13","doi-asserted-by":"publisher","unstructured":"Mahantshetty U, Naga Ch, Khadanga CR, Gudi S, Chopra S, Gurram L, et al. A prospective comparison of computerized-tomography (CT) based with trans-rectal-ultrasonography (TRUS) assistance and magnetic-resonance imaging (MRI) based target-volume definition during image guided adaptive brachytherapy for cervical cancers. Int J Radiat Oncol Biol Phys. 2018;102(5):1448\u201356. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.080.","DOI":"10.1016\/j.ijrobp.2018.05.080"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-020-01516-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T23:36:55Z","timestamp":1617665815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01516-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01516-4","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by local Research and Ethics.Board and patients were accrued after signing informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors consent publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}